The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms

TAMAR TADMOR; GUY MELAMED; HILEL ALAPI; TAL PATALON; LIOR ROKACH

doi:10.21873/anticanres.16485

Research ArticleClinical Studies

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms

TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, TAL PATALON and LIOR ROKACH

Anticancer Research July 2023, 43 (7) 3129-3134; DOI: https://doi.org/10.21873/anticanres.16485

TAMAR TADMOR

1Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Tamar.tadmor@b-zion.org.il

GUY MELAMED

2Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel-Aviv, Israel;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

HILEL ALAPI

2Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel-Aviv, Israel;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAL PATALON

2Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel-Aviv, Israel;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

LIOR ROKACH

3Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 43 no. 7 3129-3134

DOI

https://doi.org/10.21873/anticanres.16485

PubMed

37351996

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received May 8, 2023
Revision received May 25, 2023
Accepted May 29, 2023
Published online June 23, 2023.

Author Information

TAMAR TADMOR¹ ⇑,
GUY MELAMED²,
HILEL ALAPI²,
TAL PATALON² and
LIOR ROKACH³

¹Hematology Unit, Bnai Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel;
²Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel-Aviv, Israel;
³Department of Software and Information Systems Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Correspondence to: Tamar Tadmor, Hematology unit, Bnai Zion Medical Center, Golomb 47 street, Haifa, Israel 31048. Tel: +97 248359407, Fax: +97 248359962, e-mail: Tamar.tadmor{at}b-zion.org.il

View Full Text

Statistics from Altmetric.com

Cited By...

3 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma

Adolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka, Lucia Y. Chen, Bhaskar Upadhyaya, Kseniya Serebryakova, Jessica R. Nardulli, Neko Lyttle, Katerina Kappes, Hayley Jackson, Charles R. Gleason, Annika Oostenink, Gianna Y. Cai, Oliver Van Oekelen, Harm van Bakel, Emilia Mia Sordillo, Carlos Cordon-Cardo, Miriam Merad, Sundar Jagannath, Ania Wajnberg, Viviana Simon, Samir Parekh, Hala Alshammary, Dalles Andre, Radhika Banu, Katherine Beach, María Carolina Bermúdez-González, Ajai Chari, Yuexing Chen, Hearn Cho, Adolfo Firpo, Ana Silvia Gonzalez-Reiche, Eun Hye Kim, Giulio Kleiner, Florian Krammer, Jacob Mauldin, Rao Mendu, Brian Monahan, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adrianna Rossi, Ashley Salimbangon, Laryssa Sanchez, Daniel Verina

eBioMedicine 2023 98
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine

Shanti Pather, Nicola Charpentier, Frank van den Ouweland, Ruben Rizzi, Andrew Finlayson, Nadine Salisch, Alexander Muik, Claudia Lindemann, Ruzwana Khanim, Sultan Abduljawad, Emily R. Smith, Marc Gurwith, Robert T. Chen

Vaccine 2024 42 22
Increasing insight in the value of repetitive COVID‐19 vaccination in patients with haematological malignancies in the Omicron era

Ulrike Bacher, Evgenii Shumilov, Thomas Pabst

British Journal of Haematology 2023

PreviousNext

In this issue

Anticancer Research

Vol. 43, Issue 7

July 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 11 + 9 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms

TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, TAL PATALON, LIOR ROKACH

Anticancer Research Jul 2023, 43 (7) 3129-3134; DOI: 10.21873/anticanres.16485

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms

TAMAR TADMOR, GUY MELAMED, HILEL ALAPI, TAL PATALON, LIOR ROKACH

Anticancer Research Jul 2023, 43 (7) 3129-3134; DOI: 10.21873/anticanres.16485

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

Bivalent mRNA vaccine
Omicron
COVID-19
hematological neoplasms

Main menu

User menu

Search

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients With Hematological Neoplasms

Article Information

Author Information

Statistics from Altmetric.com

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords